Scandinavian Biopharma AB

Quick facts

Phase 2 pipeline

• E. coli ETVAX · Infectious Diseases
  ETVAX is a vaccine that stimulates the immune system to produce antibodies against E. coli.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Scandinavian Biopharma AB portfolio CI brief
• Scandinavian Biopharma AB pipeline updates RSS